BD has become the subject of a lawsuit from Tela Bio, with the rival maker of surgical mesh implants saying the major medtech wielded its sector dominance to push competing products out o | The rival ...
Reuters reported the suit, which was filed in the court for the Eastern District of Pennsylvania on Dec. 19. According to the ...
As the market for GLP-1 injections continues to grow, BD aims to ride that wave by providing drugmakers with its prefilled syringes. Biologic medications—including those blockbusters for diabetes and ...
Zacks Investment Research on MSN
BD and Penn Institute ink collaboration to advance immunotherapy
Becton, Dickinson and Company BDX, popularly known as BD, recently announced a collaboration with the Institute for Immunology and Immune Health (I3H) at the University of Pennsylvania to develop a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback